Issues related to pharmaceutical drug pricing (no specific legislation).
2025 · 4th Quarter (Oct 1 - Dec 31)
TEVA PHARMACEUTICALS USA, INC.
Filed by TALLEY STRATEGIES LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 21, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- TALLEY STRATEGIES LLC
- Filing UUID
- 01a68ce5-cfe2-4762-b5fe-e15ff9f5db66
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to pharmaceutical drug pricing (no specific legislation).
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.